BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Morozov VA, Lagaye S. Hepatitis C virus: Morphogenesis, infection and therapy. World J Hepatol 2018; 10(2): 186-212 [PMID: 29527256 DOI: 10.4254/wjh.v10.i2.186]
URL: https://www.wjgnet.com/1948-5182/full/v10/i2/186.htm
Number Citing Articles
1
Gulsum Ozlem Elpek. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An updateWorld Journal of Clinical Cases 2021; 9(19): 4890-4917 doi: 10.12998/wjcc.v9.i19.4890
2
Setareh Mobasheri, Nazanin Irani, Abbas Akhavan Sepahi, Fatemeh Sakhaee, Fatemeh Rahimi Jamnani, Farzam Vaziri, Seyed Davar Siadat, Abolfazl Fateh. Evaluation of TRIM5 and TRIM22 polymorphisms on treatment responses in Iranian patients with chronic hepatitis C virus infectionGene 2018; 676: 95 doi: 10.1016/j.gene.2018.07.023
3
B. Dominguez-Molina, K. Machmach, C. Perales, L. Tarancon-Diez, I. Gallego, J. L. Sheldon, M. Leal, E. Domingo, E. Ruiz-Mateos, Bryan R. G. Williams. Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic CellsJournal of Virology 2018; 92(23) doi: 10.1128/JVI.01219-18
4
Stanislas Pol, Sylvie Lagaye. The remarkable history of the hepatitis C virusMicrobes and Infection 2019; 21(5-6): 263 doi: 10.1016/j.micinf.2019.06.008
5
Johan Noble, Thomas Jouve, Paolo Malvezzi, Lionel Rostaing. Renal complications of liver diseasesExpert Review of Gastroenterology & Hepatology 2018; 12(11): 1135 doi: 10.1080/17474124.2018.1530984
6
K. Ghazal, O. Morales, C. Barjon, G. Dahlqvist, L. Aoudjehane, L. Ouaguia, N. Delhem, F. Conti. Early high levels of regulatory T cells and T helper 1 may predict the progression of recurrent hepatitis C after liver transplantationClinics and Research in Hepatology and Gastroenterology 2019; 43(3): 273 doi: 10.1016/j.clinre.2018.10.005
7
Anastasia Pechelyulko, Zhanna Andreeva-Kovalevskaya, Dmitriy Dmitriev, Viacheslav Lavrov, Yulia Massino, Alexey Nagel, Olga Segal, Olga S. Sokolova, Alexander Solonin, Yulia Tarakanova, Alexander Dmitriev. A simple method to purify recombinant HCV core protein expressed in Pichia pastoris for obtaining virus-like particles and producing monoclonal antibodiesProtein Expression and Purification 2021; 183: 105864 doi: 10.1016/j.pep.2021.105864
8
Satoshi Muraoka, Weiwei Lin, Mei Chen, Samuel W. Hersh, Andrew Emili, Weiming Xia, Tsuneya Ikezu. Assessment of separation methods for extracellular vesicles from human and mouse brain tissues and human cerebrospinal fluidsMethods 2020; 177: 35 doi: 10.1016/j.ymeth.2020.02.002
9
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation2021; : 89 doi: 10.1016/B978-0-7020-7584-1.00006-1
10
Corey Saraceni, John Birk. A Review of Hepatitis B Virus and Hepatitis C Virus ImmunopathogenesisJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00095
11
Tom Domovitz, Meital Gal-Tanamy. Tracking Down the Epigenetic Footprint of HCV-Induced HepatocarcinogenesisJournal of Clinical Medicine 2021; 10(3): 551 doi: 10.3390/jcm10030551
12
Vidya Ramdas, Rashmi Talwar, Moloy Banerjee, Advait Arun Joshi, Amit Kumar Das, Deepak Sahebrao Walke, Prashant Borhade, Usha Dhayagude, Rajesh Loriya, Ganesh Gote, Apparao Bommakanti, Aruna Sivaram, Gautam Agarwal, Arnab Goswami, Prashant Nigade, Maneesh Mehta, Vinod Patil, Dipak Modi, Hemant Kumar, Sadanand Mallurwar, Amruta Dash, Falguni Modi, Sandip Kuldharan, Pratima Srivastava, Minakshi Singh, Lakshmi Narasimham, Jayasagar Gundu, Sharad Sharma, Rajender Kumar Kamboj, Venkata P. Palle. Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical CandidateJournal of Medicinal Chemistry 2019; 62(23): 10563 doi: 10.1021/acs.jmedchem.9b01562
13
Marta M Gaglia, Karl Munger. More than just oncogenes: mechanisms of tumorigenesis by human virusesCurrent Opinion in Virology 2018; 32: 48 doi: 10.1016/j.coviro.2018.09.003
14
Kaku Goto, Armando Andres Roca Suarez, Florian Wrensch, Thomas F. Baumert, Joachim Lupberger. Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its GripInternational Journal of Molecular Sciences 2020; 21(9): 3057 doi: 10.3390/ijms21093057
15
Gema Lledó, Laura Benítez-Gutiérrez, Ana Arias, Silvia Requena, Valentín Cuervas-Mons, Carmen de Mendoza. Benefits of hepatitis C cure with antivirals: why test and treat?Future Microbiology 2019; 14(5): 425 doi: 10.2217/fmb-2019-0041
16
Vigneswaran Narayanamurthy, Z. E. Jeroish, K. S. Bhuvaneshwari, Fahmi Samsuri. Hepatitis C virus (HCV) diagnosis via microfluidicsAnalytical Methods 2021; 13(6): 740 doi: 10.1039/D0AY02045A
17
Anne Olbrich, Hedda Wardemann, Stephan Böhm, Karen Rother, Che C Colpitts, Florian Wrensch, Thomas F Baumert, Thomas Berg, Julia Benckert. Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis CThe Journal of Infectious Diseases 2019; 220(7): 1209 doi: 10.1093/infdis/jiz274
18
SK Mohiuddin Choudhury, XuSheng Ma, Sahibzada Waheed Abdullah, HaiXue Zheng. Activation and Inhibition of the NLRP3 Inflammasome by RNA VirusesJournal of Inflammation Research 2021; : 1145 doi: 10.2147/JIR.S295706
19
Mira Florea, Teodora Serban, George Razvan Tirpe, Alexandru Tirpe, Monica Lupsor-Platon. Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient ElastographyJournal of Clinical Medicine 2021; 10(12): 2575 doi: 10.3390/jcm10122575
20
Ranjan Kumar Barman, Anirban Mukhopadhyay, Ujjwal Maulik, Santasabuj Das. Identification of Critical Host Targets for HCV Infection: A Systems Biology ApproachTransactions of the Indian National Academy of Engineering 2021;  doi: 10.1007/s41403-021-00239-6
21
Maja Ružić, Rinaldo Pellicano, Milotka Fabri, Francesco Luzza, Luigi Boccuto, Snežana Brkić, Ludovico Abenavoli. Hepatitis C virus-induced hepatocellular carcinoma: a narrative reviewPanminerva Medica 2018; 60(4) doi: 10.23736/S0031-0808.18.03472-9
22
Tomás G. Villa, Ángeles Sánchez-Pérez, Carmen Sieiro. Oral lichen planus: a microbiologist point of viewInternational Microbiology 2021;  doi: 10.1007/s10123-021-00168-y
23
Shereen A Saleh, Mohamed M Salama, Marwan M Alhusseini, Ghada A Mohamed. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antiviralsWorld Journal of Gastroenterology 2020; 26(21): 2864-2876 doi: 10.3748/wjg.v26.i21.2864
24
Muhammad Kashif, Muhammad Irfan Majeed, Muhammad Asif Hanif, Ateeq ur Rehman. Surface Enhanced Raman Spectroscopy of the serum samples for the diagnosis of Hepatitis C and prediction of the viral loadsSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2020; 242: 118729 doi: 10.1016/j.saa.2020.118729
25
Simmone D'souza, Keith CK Lau, Carla S Coffin, Trushar R Patel. Molecular mechanisms of viral hepatitis induced hepatocellular carcinomaWorld Journal of Gastroenterology 2020; 26(38): 5759-5783 doi: 10.3748/wjg.v26.i38.5759
26
V. M. Tsyrkunov, V. P. Andreev, R. I. Kravchuk. CLINICAL MORPHOLOGY OF THE LIVER: HEPATOCYTES, ENDOMEMBRANE SYSTEMHepatology and Gastroenterology 2019; 3(1): 28 doi: 10.25298/2616-5546-2019-3-1-28-42
27
Sofija Sekulic, Zeljko Mijailovic, Dejan Petrovic, Ruzica Lukic, Marina Jovanovic, Ivan Jovanovic. HCV Infection and Chronic Renal DiseaseSerbian Journal of Experimental and Clinical Research 2021; 0(0) doi: 10.2478/sjecr-2021-0010
28
Hui Tian, Zhenkun He. miR-215 Enhances HCV Replication by Targeting TRIM22 and Inactivating NF-κB SignalingYonsei Medical Journal 2018; 59(4): 511 doi: 10.3349/ymj.2018.59.4.511
29
Masoud Behzadifar, Hasan Abolghasem Gorji, Aziz Rezapour, Nicola Luigi Bragazzi. The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon’s multiple streams frameworkHealth Research Policy and Systems 2019; 17(1) doi: 10.1186/s12961-019-0436-z
30
Michal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, Magdalena Bujalska-Zadrozny. Psychoactive Substances Taken with Mephedrone and HCV InfectionJournal of Clinical Medicine 2021; 10(15): 3218 doi: 10.3390/jcm10153218
31
Jia-Horng Kao, Chun-Yen Lin, Wan-Long Chuang, Yao-Yun Cheng, Jui-Yu Hu, Wen-Kai Liang, Peter Friebe, Stuart Palmer, Chin-Shiou Huang. Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotypingDiagnostic Microbiology and Infectious Disease 2019; 94(4): 344 doi: 10.1016/j.diagmicrobio.2019.02.020
32
Vukica Đorđević, Dobrila Stanković Đorđević, Branislava Kocić, Marina Dinić, Danka Sokolović, Jana Pešić Stanković, Daniele Vergara. The Impact of Hepatitis C Virus Genotypes on Oxidative Stress Markers and Catalase ActivityOxidative Medicine and Cellular Longevity 2021; 2021: 1 doi: 10.1155/2021/6676057
33
Teshiwal Deress, Yihenew Million, Teshome Belachew, Mohabaw Jemal, Mekonnen Girma, Gianandrea Pasquinelli. Seroprevalence of Hepatitis C Viral Infection in Ethiopia: A Systematic Review and Meta-AnalysisThe Scientific World Journal 2021; 2021: 1 doi: 10.1155/2021/8873389
34
Stanislas Pol, Sylvie Lagaye. The remarkable history of the hepatitis C virusGenes & Immunity 2019; 20(5): 436 doi: 10.1038/s41435-019-0066-z
35
Talari Praveen. Advances in Hepatology [Working Title]2021;  doi: 10.5772/intechopen.96734
36
Simona Georgescu, Mircea Tampa, Madalina Mitran, Cristina Mitran, Maria Sarbu, Ilinca Nicolae, Clara Matei, Constantin Caruntu, Monica Neagu, Mircea Popa. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection (Review)Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6987
37
Ahmed S. Abdel‐Moneim. Occult hepatitis C infections: time to change the defined groupsMicrobiology and Immunology 2019; 63(11): 474 doi: 10.1111/1348-0421.12737
38
G.S. Pancar, T. Kaynar. Nailfold capillaroscopic changes in patients with chronic viral hepatitisMicrovascular Research 2020; 129: 103970 doi: 10.1016/j.mvr.2019.103970
39
Sara Abouelasrar Salama, Muriel Lavie, Mieke De Buck, Jo Van Damme, Sofie Struyf. Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infectionCytokine & Growth Factor Reviews 2019; 50: 29 doi: 10.1016/j.cytogfr.2019.10.006
40
Antoni Sicras Mainar, Ruth Navarro Artieda, Ignacio Hernández, Ramón Morillo. Prevalencia de las potenciales interacciones medicamentosas entre los antivirales de acción directa pangenotípicos y la medicación concomitante asociada a los pacientes con infección del virus de la hepatitis C crónica en EspañaGastroenterología y Hepatología 2019; 42(8): 465 doi: 10.1016/j.gastrohep.2019.03.014
41
Thanjavur Naveen, Lankipalli Tharachand Naidu, Rayi Ramesh, Mekala Charitha Devi. Recent Developments in Applied Microbiology and Biochemistry2021; : 35 doi: 10.1016/B978-0-12-821406-0.00005-9
42
María Fernanda Guerra, Javier Ampuero, Manuel Romero‐Gómez. Clinical Dilemmas in Viral Liver Disease2020; : 59 doi: 10.1002/9781119533481.ch10
43
Noha H. Habashy, Marwa M. Abu-Serie. Major royal-jelly protein 2 and its isoform X1 are two novel safe inhibitors for hepatitis C and B viral entry and replicationInternational Journal of Biological Macromolecules 2019; 141: 1072 doi: 10.1016/j.ijbiomac.2019.09.080
44
Antoni Sicras Mainar, Ruth Navarro Artieda, Ignacio Hernández, Ramón Morillo. Prevalence of the potential drug–drug interactions between pangenotypic direct-acting antivirals and the concomitant medications associated with patients with chronic hepatitis C virus infection in SpainGastroenterología y Hepatología (English Edition) 2019; 42(8): 465 doi: 10.1016/j.gastre.2019.09.001
45
Shahina Mumtaz, Jawad Ahmed, Amina Gul, Shafiq Ahmed Tariq, Sami Siraj, Tahir Sarwar. Genetic Diversity of Hepatitis C Virus Genotype 3a Based on Complete Core Protein in Peshawar, PakistanJundishapur Journal of Microbiology 2020; 13(3) doi: 10.5812/jjm.98942